How Many mg Is 75 Units of Tirzepatide? Understanding Dosage and Concentration for Effective Weight Loss

Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide dosing can feel confusing when you see measurements in both units and milligrams. A 75-unit dose of tirzepatide typically equals 2.25 milligrams when formulated at a standard 10 mg/3 mL concentration, though the exact conversion depends on your specific compounding pharmacy's preparation. PlexusDx sources all tirzepatide from licensed 503A compounding pharmacies, ensuring consistent, precision-calibrated doses that match your individual metabolic needs.

Understanding Tirzepatide Units vs. Milligrams

Tirzepatide comes in two measurement systems: units and milligrams. One unit of tirzepatide equals 0.03 milligrams when expressed in standard pharmaceutical terms. This means a 75-unit injection delivers 2.25 milligrams of the active compound. However, the actual volume you inject depends on the concentration formulated by your compounding pharmacy. A 10 mg/mL concentration would require 0.225 milliliters, while a 3 mg/mL concentration would require 0.75 milliliters for the same 75-unit dose.

Concentration matters because it affects injection volume and comfort. Pharmacies can prepare tirzepatide at various strengths to optimize needle gauge, injection frequency, and patient experience. PlexusDx works exclusively with licensed 503A compounding pharmacies that maintain strict quality standards and provide transparent concentration specifications. Understanding your specific formulation helps you track dosing accurately and anticipate what to expect during each weekly injection.

How Tirzepatide Dosing Progression Works for Weight Loss

Tirzepatide typically follows a stepwise titration schedule during the first 16 weeks of treatment. Most patients begin at 2.5 mg (approximately 83 units) weekly, then increase by 2.5 mg increments every four weeks until reaching their therapeutic dose. A 75-unit maintenance dose represents a mid-range step in this progression, commonly used for patients who need moderate appetite suppression and metabolic enhancement. The dose-escalation approach allows your body to adjust to the medication while minimizing nausea and other gastrointestinal side effects.

Your dose may need to go up, but your price won't. PlexusDx charges a flat monthly rate of $289 for compounded tirzepatide injection regardless of which step you're on in your titration schedule. This transparent pricing model removes financial barriers to reaching your optimal therapeutic dose. Many patients find their sweet spot between 5 mg and 10 mg weekly, though some require higher doses based on their genetics, weight, and metabolic response.

Why Concentration and Compounding Quality Affect Your Results

Not all compounded tirzepatide formulations are created equal. Licensed 503A compounding pharmacies must meet strict United States Pharmacopeia (USP) standards for purity, potency, and sterility. The concentration your pharmacy chooses affects bioavailability—how effectively your body absorbs and utilizes the medication. A properly formulated tirzepatide injection at any strength delivers consistent results when manufactured under pharmaceutical-grade conditions. PlexusDx partners exclusively with 503A compounders who provide certificates of analysis and maintain rigorous quality control, ensuring that your 75-unit dose contains exactly what the label states.

Consistency in compounding directly impacts weight loss outcomes. Clinical trials demonstrating tirzepatide's effectiveness used precisely formulated injections with verified concentrations. When you receive compounded medication from a licensed pharmacy, you receive that same level of precision. This commitment to quality extends across all PlexusDx formulations, including our Compounded Tirzepatide Injection at $289/mo month-to-month, or from $249/mo on the 6-month plan, oral tirzepatide options, and combination protocols designed for maximum metabolic support.

Personalized Dosing With Genetic Testing and PlexusDx

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437) and FTO (rs9939609) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Genetic insights remove guesswork from dose optimization. Some patients carry genetic variants associated with reduced GLP-1 receptor sensitivity, meaning they achieve superior results with higher tirzepatide doses or dual-compound protocols. Others show optimal response at lower doses, minimizing side effects while maximizing weight loss. PlexusDx's precision approach means your clinician personalizes your starting dose, titration schedule, and target dose based on clinical evidence plus your unique genetic profile—ensuring that your 75-unit dose (or whatever dose becomes your therapeutic target) delivers meaningful, lasting results.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is 75 units of tirzepatide a standard dose for weight loss?

A 75-unit dose (2.25 mg) falls within the early-to-mid range of tirzepatide dosing. Most weight loss protocols progress through doses starting at 83 units (2.5 mg) and escalating weekly. Your clinician may recommend 75 units during titration or as a maintenance dose if you've experienced side effects at higher levels. PlexusDx works with your response to determine the optimal dose for your goals, with pricing that stays flat regardless of dose level.

How does tirzepatide dosing compare to semaglutide for weight loss?

Tirzepatide activates both GLP-1 and GIP receptors, delivering dual metabolic stimulation, while semaglutide targets only GLP-1 receptors. Clinical trials show tirzepatide produces greater weight loss at comparable doses—typically 20-22% of baseline body weight versus 15-17% for semaglutide. A 75-unit tirzepatide dose may produce equivalent results to a higher semaglutide dose. PlexusDx offers both medications at transparent flat pricing, plus the Precision Peptide Genetic Test to describe the pathway-level variants involved.

What does compounded tirzepatide cost at PlexusDx?

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) across all doses, including 75 units and higher. HSA and FSA accounts are eligible. No membership fee or insurance is required, and PlexusDx serves all 50 states. Your dose may increase during titration, but your monthly price remains flat.

Are there side effects I should expect at a 75-unit tirzepatide dose?

At mid-range doses like 75 units, most patients experience manageable nausea, reduced appetite, and occasional digestive changes that typically improve within one to two weeks. Serious adverse events are rare with compounded tirzepatide from licensed pharmacies. If side effects persist, your PlexusDx clinician can adjust your titration schedule or recommend lower doses. Always report unexpected symptoms to your healthcare provider.

How does the Precision Peptide Genetic Test help optimize my tirzepatide dose?

PlexusDx's Precision Peptide Genetic Test ($298) maps your GLP-1 receptor sensitivity, GIP receptor function, and metabolic gene variants across 14 pathways. Patients with genetic variants associated with lower GLP-1R sensitivity may achieve better results escalating past 75 units, while others show optimal response at lower doses. This personalized insight accelerates you toward your most effective therapeutic dose while minimizing trial-and-error dosing.

Related Reading

• Tirzepatide For Weight Loss 2
• Glp 1 Dosage For Weight Loss
• Tirzepatide Vs Semaglutide For Weight Loss
• Tirzepatide For Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.